Built from Acadia Healthcare Company, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$38.79+0.5%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed November 4, 2026
Company outlook: revenue of $3.4B to $3.5B for Fiscal year 2026 — up 4.1% on a year earlier
Just reported
From Acadia Healthcare's results release of November 4, 2026; its quarterly report has since been filed.
Actual
$895.3M
+5.1% y/y
+3.4% q/q
Guided
—
No guide given
Actual
$0.38
-5.0% y/y
+217% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Acadia Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Grade C
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 31 quarters of Acadia Healthcare Company, Inc.’s grade history. The other 29 go back to March 2019.
